Comparison between two models of experimental anxiety in healthy volunteers and panic disorder patients

Neuroscience and Biobehavioral Reviews

Volumn 25, Issue 7-8, 2001, Pages 753-759

  Graeff, Frederico G ^a   Silva, Marilei ^a   Del Ben, Cristina M ^a   Zuardi, Antônio W ^a   Hetem, Luiz A B ^a   Guimarães, Francisco S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

5 HT; Conditioning of skin conductance response; Experimental anxiety; Healthy volunteers; Panic patients; Simulated public speaking

Indexed keywords

BENZODIAZEPINE; CLOMIPRAMINE; FENFLURAMINE; LORAZEPAM; METERGOLINE; NEFAZODONE; RITANSERIN; SEROTONIN; SEROTONIN 2A ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANXIETY; ARTICLE; COMPARATIVE STUDY; CONDITIONING; DIAGNOSTIC TEST; DRUG EFFECT; ELECTRODERMAL RESPONSE; FEAR; HUMAN; NOISE; PANIC; PRIORITY JOURNAL; SEROTONIN RELEASE; SIMULATION; SKIN CONDUCTANCE; SPEECH; STIMULUS RESPONSE; VOLUNTEER;

EID: 0035709447     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(01)00055-0     Document Type: Short Survey

References (49)

1. Relaxation-induced panic (RIP): When resting is not peaceful
2. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study
3. 2-induced anxiety in healthy volunteers with the serotonin antagonist metergoline
4. Modification of the serotonin system by the antidepressant treatments: Implications for the therapeutic response in major depression
5. The influence of ritanserin, a serotonin antagonist in anxiety disorders: A double-blind placebo-controlled study versus lorazepam
6. 5-HT and mechanisms of defence
7. Testing 5-HT theories of anxiety in normal volunteers
8. Early clinical experience with ritanserin in neurotic patients
9. Do panic patients process unconditioned fear versus conditioned anxiety differently from normal subjects?
10. Serotonin function in panic disorder: A double blind placebo controlled study with fluvoxamine and ritanserin
11. Social phobia in the general population: Prevalence and sociodemographic profile
12. The aversive system, 5HT and panic attacks
13. Animal model of aversion
14. Brain defense systems and anxiety
15. Neurotransmitters in the dorsal periaqueductal gray and animal models of panic anxiety
16. Dual role of 5-HT in defense and anxiety
17. Role of 5-HT in stress, anxiety and depression
18. Role of the amygdala and periaqueductal gray in anxiety and panic
19. Effect of metergoline on human anxiety
20. Ritanserin facilitates anxiety in simulated public-speaking paradigm
21. Effect of chlorimipramine and maprotiline on experimental anxiety in humans
22. Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: Influence of gender, instructions, personality and placebo
23. The effects of ritanserin on aversive classical conditioning in humans
24. Addition of D-fenfluramine to benzodiazepines produced a marked improvement in refractory panic disorder - A case report
25. Effect of D-fenfluramine on human experimental anxiety
26. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination
27. Panic disorder: Pathophysiology and drug treatment
28. A model of panic and agoraphobic development
29. The definition and psychopharmacology of spontaneous panic and phobia
30. Panic disorder - A malfunction of multiple transmitter control systems within the midbrain periaqueductal gray matter?
31. Simulated public speaking as a model of clinical anxiety
32. D-Fenfluramine in panic disorder: A dual role for 5-hydroxytryptamine
33. The action of sedatives on brainstem oculomotor systems in man
34. Anxiety induced by simulated public speaking and stroop colour word test in healthy subjects: Effects of different trait-anxiety levels
35. Normative data for the personal report of confidence as a speaker
36. Anti-aversive role of serotonin in the dorsal periaqueductal grey matter
37. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and D-fenfluramine pretreatment attenuates D-fenfluramine-evoked release of 5-HT in vivo
38. Opposed effects of nefazodone in two human models of anxiety
39. Controlling panic attacks with fenfluramine
40. Setting diagnostic thresholds for social phobia: Considerations from a community survey of social anxiety
41. Fenfluramine provocation of anxiety in patients with panic disorder
42. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug
43. Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray
44. D-Fenfluramine selectively releases 5-HT from dorsal raphe terminals
45. Vulnerability and conditioning in relation to the human menstrual cycle
46. Changes in psychophysiological and conditioning variables during chlomethiazole-medicated and unmedicated ethanol withdrawal: Preliminary report
47. Estudo transcultural de uma escala de auto-avaliação para estados subjetivos